| Value | ₹9.00 Cr |
|---|---|
| Execution period | 2 years |
BSE filing, NSE: GUJAPOLLO. Summary written from the filing by ALFA Finder's alert engine.
Gujarat Apollo Industries Ltd: key numbers
- Share price
- ₹348.90
- Market cap
- ₹452.5 Cr
- Revenue (annual)
- ₹52.98 Cr
- Net profit (annual)
- ₹5.95 Cr
- P/E (TTM)
- 80.7×Sector 51.7×
- Promoter holding
- 47.30%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gujarat Apollo Industries Ltd
All →Gujarat Apollo Industries Other Announcement
The company filed its quarterly shareholding pattern for the period ended September 30, 2026, pursuant to SEBI Regulation 31.
Gujarat Apollo Industries Merger & Restructuring Worth ₹37.63 Cr
Gujarat Apollo Industries completed the sale of its entire 17.92% stake in Credo Advanced Chemicals Limited for ₹37.63 Crore. The company no longer holds CACL shares.
- Value
- ₹37.63 Cr
Gujarat Apollo Industries Annual General Meeting
Gujarat Apollo Industries Limited held its 39th Annual General Meeting on September 28, 2026, to discuss financial results, director reappointments, dividends, and a proposed business divestment.
Gujarat Apollo Industries Annual General Meeting
Gujarat Apollo Industries filed its 39th Annual Report and AGM Notice for September 28, 2026. Agenda includes a dividend declaration and the ₹37.63 Crore stake divestment.
- Value
- ₹37.63 Cr
Gujarat Apollo Industries Annual General Meeting
Gujarat Apollo Industries will hold its 39th AGM on September 28, 2026. The record date for dividend eligibility and voting is set for September 21, 2026.
Gujarat Apollo Industries Board Meeting Outcome
Gujarat Apollo Industries approved the 39th AGM notice, fixed a record date, and approved the sale of its investment in Credo Advanced Chemicals Limited.
- Value
- ₹37.63 Cr
Other capacity expansion announcements
All →Global Health Capacity Expansion: ₹997 Cr Investment
Medanta plans a 500-bed Ghaziabad hospital over 3-4 years. Project cost is Rs 997 Crore, funded by internal accruals and debt.
- Value
- ₹997.0 Cr
- Execution
- 3-4 years, phased
- hospital beds
- 500.0 beds
Gujarat Inject (Kerala) Capacity Expansion
Gujarat Inject Kerala Ltd leased two Ahmedabad industrial premises for factory and R&D use. The five-year deals include 5% escalation and a two-year lock-in.
- Execution
- 5 years (2-year lessee lock-in)
Aelea Commodities Capacity Expansion: ₹114 Cr Investment
Aelea's board approved ₹114 crore to add 90 MT manufacturing capacity and build a staff housing colony in Surat. Completion expected within 30 months from February 2027.
- Value
- ₹114.0 Cr
- Execution
- 30 months from February 2027
- manufacturing capacity addition
- 90.0 MT
Kaynes Technology India Capacity Expansion
Kaynes Technology has incorporated a wholly owned subsidiary, Kaynes Arabia Electronics Company, in Saudi Arabia to manufacture electronic products for GCC markets. The company holds 100% ownership and the authorised share capital is SAR 100,000.
Vaibhav Vyapaar Capacity Expansion
Vaibhav Vyapaar opened a new business office in Bangalore, commencing operations on 02 November 2026. The approximately 5,500 sq ft office supports operational expansion.
- office area
- 5500.0 sq ft
Borana Weaves Capacity Expansion: ₹49.92 Cr Investment
Borana Weaves plans 384 new looms, adding 110.60 million metres of yearly capacity. The Rs 49.92 Crore investment will be phased through March 2027.
- Value
- ₹49.92 Cr
- Execution
- Phase 1 by December 2026; Phase 2 by March 2027
- annual greige fabric production capacity
- 110.6 million metres per year